EMEA Archives - Kotter International Inc

European steel or cement plant representing CBAM-affected industries

AI + Digital Transformation Blog EMEA Energy + Natural Resources Kotter Insights Leading Through Crisis Manufacturing Operational Efficiency

CBAM Compliance Alone Is Not Enough

Compliance alone will not prepare companies for CBAM’s definitive phase. Leaders must mobilize cross-functional teams,…

Nick PetschekFebruary 23, 2026

Counterfeit drugs are rising as viral demand outpaces regulation. Learn how pharma leaders can protect trust, safety, and innovation.

Blog EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

Question of Trust: How Pharma Leaders Can Respond to Counterfeit Drug Risk

The news that Hein Schumacher is set to take over from Barry Callebaut CEO Peter…

Nick PetschekFebruary 2, 2026

Blog Culture Change EMEA Kotter In The News Kotter Insights Leading Through Crisis Retail

Barry Callebaut leadership reset – why and what come next?

The news that Hein Schumacher is set to take over from Barry Callebaut CEO Peter…

Nick PetschekJanuary 27, 2026

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in ways that were unimaginable a decade ago. Yet despite these advances, sustaining innovation has become harder than ever. Development costs are climbing, competition for talent is intensifying and many of the most exciting early-stage innovations are now coming from biotech and academic partners. At the same time, a new generation of scientists is entering the field with different expectations. They look for trust, adaptability and purpose, not rigid hierarchies and incremental progress.

Blog Culture Change EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

The Future of Pharma R+D Leadership

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in…

Nick PetschekJanuary 27, 2026

AI + Digital Transformation Blog Culture Change EMEA Healthcare Innovation Kotter In The News Kotter Insights Pharma + Biotech Technology

When Innovation Outpaces Regulation

Addressing the threat of unlicensed drugs requires coordinated action across every industry tier, from pharma…

Nick PetschekJanuary 15, 2026

HR Magazine Article with Kotter Inc's Tom Halton as a contributor

Blog Culture Change EMEA Human Resources Kotter In The News Kotter Insights Leading Through Crisis Nonprofit Resource Restructuring Workplace

Oxfam CEO leaves after review finds breached values

In a statement to the Telegraph, an Oxfam representative said that the findings of the…

Tom HaltonDecember 16, 2025

AI + Digital Transformation Blog Culture Change EMEA Financial Services + Insurance Government Innovation Kotter In The News Kotter Insights Leadership Development Resource Technology

Why Your Compliance Training Won’t Stop the Next Cyber-Attack

Nick PetschekNovember 24, 2025

Energy Intelligence Article by Kotter's Nick Petschek managing director for Europe, the Middle East and Africa at Kotter, a strategy execution, change management, training and transformation consultancy.

Blog Case Study Culture Change EMEA Energy + Natural Resources Government Innovation Kotter In The News Kotter Insights Leadership Development Operational Efficiency Resource

Preventing the Next Blackout: Lessons for Europe’s Grid

Nick PetschekNovember 11, 2025

Culture Change EMEA Human Resources Innovation Kotter In The News Kotter Insights Leadership Development

Informa CEO relocates to UAE

Nick PetschekNovember 6, 2025

Culture Change EMEA Employee Engagement Employee Retention Energy + Natural Resources Growth Innovation Kotter In The News Kotter Insights Leadership Development M&A Integration Operational Efficiency Productivity Restructuring Workplace

The India-UK Energy Deal: Why Utilities Must Prepare

Nick PetschekSeptember 29, 2025

EMEA

CBAM Compliance Alone Is Not Enough

Question of Trust: How Pharma Leaders Can Respond to Counterfeit Drug Risk

Barry Callebaut leadership reset – why and what come next?

The Future of Pharma R+D Leadership

When Innovation Outpaces Regulation

Oxfam CEO leaves after review finds breached values

Why Your Compliance Training Won’t Stop the Next Cyber-Attack

Preventing the Next Blackout: Lessons for Europe’s Grid

Informa CEO relocates to UAE

The India-UK Energy Deal: Why Utilities Must Prepare

Work With Us

Learn With Us

Talk With Us